Report
EUR 13.71 For Business Accounts Only

HU GROUP HOLDINGS sees a downgrade to Neutral on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of HU GROUP HOLDINGS (JP), active in the Pharmaceuticals industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered defensive. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Neutral. As of the analysis date March 8, 2022, the closing price was JPY 2,876.00 and its target price was estimated at JPY 2,534.96.
Underlying
H.U.Group Holdings Inc.

Miraca Holdings is a holding company mainly engaged in the manufacture and sale of clinical reagents for agglutination and serology testing. Co. is engaged in the development, manufacture and sale of in vitro diagnostic reagents, including test reagents and testing devices mainly in the fields of infectious and oncological diseases to medical institutions and commercial laboratories; and the provision of all-round laboratory testing services, including general testing and esoteric testing, clinical trial-related services to support pharmaceutical research and development, as well as sterilization-outsourcing services of reusable medical and surgical instruments.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch